Tag: Mycobacterium abscessus

According to the American Thoracic Society (ATS), effective treatments for NTM infections are often suboptimal, with high rates of relapse or reinfection observed in some cases. This makes understanding **what is the best treatment for NTM?** a complex question, as the optimal approach is highly dependent on the specific species involved and the patient's condition.

Nontuberculous mycobacterial (NTM) infections are becoming increasingly prevalent worldwide [1.2.2]. A key question for clinicians and patients is: **What antibiotics treat *Mycobacterium abscessus*?** This bacterium is known for its extensive drug resistance, making treatment particularly challenging [1.7.5].